| Drug General Information |
| Drug ID |
D0OD8N
|
| Former ID |
DNC002781
|
| Drug Name |
1-Methoxy-2-[2-(2-Methoxy-Ethoxy]-Ethane
|
| Drug Type |
Small molecular drug
|
| Indication |
Discovery agent
|
Investigative |
[1]
|
|---|
| Structure |
|
Download
2D MOL
3D MOL
|
| Formula |
C8H18O4
|
| Canonical SMILES |
COCCOCCOCCOC
|
| InChI |
1S/C8H18O4/c1-9-3-5-11-7-8-12-6-4-10-2/h3-8H2,1-2H3
|
| InChIKey |
YFNKIDBQEZZDLK-UHFFFAOYSA-N
|
| PubChem Compound ID |
|
| PubChem Substance ID |
111461, 823039, 836781, 3134745, 7527112, 7889819, 8155727, 10504280, 12080089, 14769627, 24900334, 26718198, 26744269, 26757434, 35227175, 46505275, 48424234, 49854135, 49854749, 56365719, 57324834, 57654684, 57654967, 80932548, 81054184, 81061371, 81061744, 85090078, 85248226, 85261542, 87219177, 87350068, 87350090, 87350113, 87350132, 87350154, 87563525, 87692932, 91702443, 92093377, 92251941, 92309532, 93617493, 93617772, 96021966, 103851581, 103911337, 104251404, 104317161, 117500302
|
| Target and Pathway |
| Target(s) |
Transketolase |
Target Info |
Inhibitor |
[1]
|
|---|
| Fyn tyrosine kinase |
Target Info |
Inhibitor |
[1]
|
|
BioCyc Pathway
|
Pentose phosphate pathway
|
|
Pentose phosphate pathway (non-oxidative branch)
|
|
KEGG Pathway
|
Pentose phosphate pathway
|
|
Metabolic pathways
|
|
Biosynthesis of antibiotics
|
|
Carbon metabolism
|
|
Biosynthesis of amino acidshsa04071:Sphingolipid signaling pathway
|
|
Axon guidance
|
|
Osteoclast differentiation
|
|
Focal adhesion
|
|
Adherens junction
|
|
Platelet activation
|
|
Natural killer cell mediated cytotoxicity
|
|
T cell receptor signaling pathway
|
|
Fc epsilon RI signaling pathway
|
|
Cholinergic synapse
|
|
Prion diseases
|
|
Pathogenic Escherichia coli infection
|
|
Measles
|
|
Viral myocarditis
|
|
NetPath Pathway
|
TSH Signaling Pathway
|
|
IL2 Signaling Pathway
|
|
TGF_beta_Receptor Signaling Pathway
|
|
PANTHER Pathway
|
Pentose phosphate pathwayP00007:Axon guidance mediated by semaphorins
|
|
Cadherin signaling pathway
|
|
Integrin signalling pathway
|
|
Parkinson disease
|
|
Pathway Interaction Database
|
Fc-epsilon receptor I signaling in mast cells
|
|
ErbB4 signaling events
|
|
Glypican 1 network
|
|
TCR signaling in naï
|
|
Signaling events mediated by PTP1B
|
|
Ephrin A reverse signaling
|
|
Reelin signaling pathway
|
|
Regulation of p38-alpha and p38-beta
|
|
TCR signaling in naï
|
|
Angiopoietin receptor Tie2-mediated signaling
|
|
Thromboxane A2 receptor signaling
|
|
Netrin-mediated signaling events
|
|
IL2-mediated signaling events
|
|
CXCR4-mediated signaling events
|
|
Class I PI3K signaling events
|
|
Posttranslational regulation of adherens junction stability and dissassembly
|
|
amb2 Integrin signaling
|
|
EPHA forward signaling
|
|
E-cadherin signaling in keratinocytes
|
|
PDGFR-beta signaling pathway
|
|
Nephrin/Neph1 signaling in the kidney podocyte
|
|
Signaling events mediated by VEGFR1 and VEGFR2
|
|
Syndecan-3-mediated signaling events
|
|
Ephrin B reverse signaling
|
|
Alpha-synuclein signaling
|
|
Signaling events mediated by focal adhesion kinase
|
|
PathWhiz Pathway
|
Pentose Phosphate Pathway
|
|
Warburg EffectPW000453:Fc Epsilon Receptor I Signaling in Mast Cells
|
|
Reactome
|
GPVI-mediated activation cascade
|
|
PIP3 activates AKT signaling
|
|
Regulation of KIT signaling
|
|
Cell surface interactions at the vascular wall
|
|
FCGR activation
|
|
PECAM1 interactions
|
|
Constitutive Signaling by Aberrant PI3K in Cancer
|
|
DAP12 signaling
|
|
EPH-Ephrin signaling
|
|
Role of LAT2/NTAL/LAB on calcium mobilization
|
|
Nephrin interactions
|
|
NCAM signaling for neurite out-growth
|
|
CD28 co-stimulation
|
|
CD28 dependent PI3K/Akt signaling
|
|
CD28 dependent Vav1 pathway
|
|
CTLA4 inhibitory signaling
|
|
EPHB-mediated forward signaling
|
|
EPHA-mediated growth cone collapse
|
|
EPH-ephrin mediated repulsion of cells
|
|
CRMPs in Sema3A signaling
|
|
DCC mediated attractive signaling
|
|
Netrin mediated repulsion signals
|
|
VEGFA-VEGFR2 Pathway
|
|
Dectin-2 family
|
|
CD209 (DC-SIGN) signaling
|
|
RAF/MAP kinase cascade
|
|
Platelet Adhesion to exposed collagen
|
|
Regulation of signaling by CBL
|
|
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
|
|
WikiPathways
|
Metabolism of carbohydrates
|
|
Integration of energy metabolism
|
|
Pentose Phosphate PathwayWP69:TCR Signaling Pathway
|
|
Interferon type I signaling pathways
|
|
IL-2 Signaling Pathway
|
|
Kit receptor signaling pathway
|
|
IL-3 Signaling Pathway
|
|
Ectoderm Differentiation
|
|
Fc epsilon receptor (FCERI) signaling
|
|
Signaling by the B Cell Receptor (BCR)
|
|
Signaling by SCF-KIT
|
|
DAP12 interactions
|
|
Host Interactions of HIV factors
|
|
PIP3 activates AKT signaling
|
|
T-Cell Receptor and Co-stimulatory Signaling
|
|
Primary Focal Segmental Glomerulosclerosis FSGS
|
|
BDNF signaling pathway
|
|
Interleukin-11 Signaling Pathway
|
|
B Cell Receptor Signaling Pathway
|
|
Pathogenic Escherichia coli infection
|
|
TSLP Signaling Pathway
|
|
IL-7 Signaling Pathway
|
|
Leptin signaling pathway
|
|
Semaphorin interactions
|
|
Platelet Adhesion to exposed collagen
|
|
Netrin-1 signaling
|
|
Nephrin interactions
|
|
NCAM signaling for neurite out-growth
|
|
Integrin-mediated Cell Adhesion
|
|
GPVI-mediated activation cascade
|
|
Costimulation by the CD28 family
|
|
Cell surface interactions at the vascular wall
|
| References |
| REF 1 | How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. |
|---|
